Safety Study of SLV213 for the Treatment of COVID-19.
- Conditions
- COVID-19
- Interventions
- Other: Placebo for SLV213Drug: SLV213
- First Posted Date
- 2023-11-24
- Last Posted Date
- 2024-10-03
- Target Recruit Count
- 16
- Registration Number
- NCT06146374
- Locations
- ๐บ๐ธ
Altasciences Inc - Kansas City, Overland Park, Kansas, United States
Protocol CAUSE-03 / CHEETAH
- Conditions
- Asthma
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2024-05-06
- Target Recruit Count
- 310
- Registration Number
- NCT06136091
- Locations
- ๐บ๐ธ
Children's Hospital Colorado: Allergy Program, Aurora, Colorado, United States
๐บ๐ธChildren's National Medical Center: Children's Research Institute, Washington, District of Columbia, United States
๐บ๐ธBoston University School of Medicine: Pulmonary Center, Boston, Massachusetts, United States
A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2025-01-03
- Target Recruit Count
- 12
- Registration Number
- NCT06118515
- Locations
- ๐บ๐ธ
Medical College of Wisconsin, Milwaukee, Wisconsin, United States
๐บ๐ธChildren's of Alabama Child Health Research Unit (CHRU), Birmingham, Alabama, United States
๐บ๐ธChildren's National Medical Center - Sheikh Zayed Campus - Infectious Disease, Washington, District of Columbia, United States
Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers
- Conditions
- Healthy
- First Posted Date
- 2023-11-07
- Last Posted Date
- 2024-12-04
- Target Recruit Count
- 120
- Registration Number
- NCT06120244
- Locations
- ๐บ๐ธ
Rocky Mountain Laboratories, Hamilton, Montana, United States
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
- Conditions
- Liver Transplant
- Interventions
- Drug: CMV-MVA TriplexDrug: Placebo for CMV-MVA Triplex
- First Posted Date
- 2023-10-10
- Last Posted Date
- 2024-12-27
- Target Recruit Count
- 416
- Registration Number
- NCT06075745
- Locations
- ๐บ๐ธ
University of Alabama at Birmingham, School of Medicine, Birmingham, Alabama, United States
๐บ๐ธUniversity of California, San Diego School of Medicine, La Jolla, California, United States
๐บ๐ธStanford University, Redwood City, California, United States
Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
- Conditions
- HIV-1-infection
- Interventions
- Biological: PlaceboBiological: ChAdOx1.tHIVconsv1Biological: ChAdOx1.HIVconsv62Biological: MVA.tHIVconsv3Biological: MVA.tHIVconsv4Drug: Vesatolimod (VES)Drug: GS-5423Drug: GS-2872
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2024-04-09
- Target Recruit Count
- 45
- Registration Number
- NCT06071767
- Locations
- ๐บ๐ธ
Ponce de Leon Center CRS, Atlanta, Georgia, United States
๐บ๐ธPenn Therapeutics CRS, Philadelphia, Pennsylvania, United States
๐บ๐ธColumbia Physicians & Surgeons CRS, New York, New York, United States
Advancing Transplantation Outcomes in Children
- Conditions
- Kidney Transplant
- Interventions
- Drug: SirolimusDrug: Mycophenolate MofetilBiological: BelataceptDrug: Tacrolimus (Group 2)Drug: Tacrolimus (Group1)Drug: Anti-Thymocyte Globulin (ATG)
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2024-12-10
- Target Recruit Count
- 200
- Registration Number
- NCT06055608
- Locations
- ๐บ๐ธ
University of Alabama at Birmingham (Site # 71038), Birmingham, Alabama, United States
๐บ๐ธChildren's Hospital of Los Angeles (Site #: 71036), Los Angeles, California, United States
๐บ๐ธCedars-Sinai Medical Center (Site #: 71026), Los Angeles, California, United States
CAR-T Cell Therapy for Desensitization in Kidney Transplantation
- Conditions
- End Stage Renal Failure on DialysisKidney FailureKidney Transplant
- Interventions
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2025-01-08
- Target Recruit Count
- 20
- Registration Number
- NCT06056102
- Locations
- ๐บ๐ธ
NYU Langone Health (Site #: 71177), New York, New York, United States
๐บ๐ธMassachusetts General Hospital: Transplantation (Site #: 71107), Boston, Massachusetts, United States
๐บ๐ธUniversity of Pennsylvania Medical Center (Site #: 71111), Philadelphia, Pennsylvania, United States
A Trial to Evaluate an HIV Envelope Trimer, N332-GT5 gp140, Adjuvanted With SMNP in Adult Participants Without HIV
- Conditions
- HIV
- Interventions
- Biological: N332-GT5 gp140 (IM, Bolus)Biological: N332-GT5 gp140 (SC, Bolus)Biological: N332-GT5 gp140 (IM, Fractioned)Biological: N332-GT5 gp140 (SC, Fractioned)Biological: SMNP (IM, Bolus)Biological: SMNP (SC, Bolus)Biological: SMNP (IM, Fractioned)Biological: SMNP (SC, Fractioned)
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2024-11-05
- Target Recruit Count
- 84
- Registration Number
- NCT06033209
- Locations
- ๐บ๐ธ
Bridge HIV CRS, San Francisco, California, United States
๐บ๐ธUCSF School of Medicine, San Francisco, California, United States
๐บ๐ธAtlanta - Hope Clinic, Decatur, Georgia, United States
Tocilizumab in Lung Transplantation
- Conditions
- Lung Transplant
- Interventions
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2024-12-24
- Target Recruit Count
- 350
- Registration Number
- NCT06033196
- Locations
- ๐บ๐ธ
St. Joseph's Hospital and Medical Center (Site #: 71192), Phoenix, Arizona, United States
๐บ๐ธCedars Sinai Medical Center (Site #: 71146), Los Angeles, California, United States
๐บ๐ธDavid Geffen School of Medicine at UCLA (Site #: 71123), Los Angeles, California, United States